Goodman et al. used genomic profiling with FoundationOne assay covering maximum 405 cancer-related genes to study tumor samples from commercial database, and identified only 18 cases with PD-L1 amplification from total 9851 CRC samples. This evidence concerns the gene CD274 and colorectal carcinoma.